D
Nektar Therapeutics NKTR
$0.8968 $0.08149.98%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue -0.08% 14.59% 0.21% 8.45% 2.20%
Total Other Revenue -- -- -- -- --
Total Revenue -0.08% 14.59% 0.21% 8.45% 2.20%
Cost of Revenue -64.32% 39.26% 20.88% 16.85% 150.02%
Gross Profit 68.10% 1.81% -9.83% 5.14% -37.21%
SG&A Expenses -10.36% 14.78% -4.42% -21.05% -6.16%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 1.34% 9.96% -4.30% -13.30% -5.64%
Operating Income -2.37% -7.17% 6.93% 25.02% 10.59%
Income Before Tax 19.28% -2.24% 73.13% 25.53% 22.47%
Income Tax Expenses 114.75% 197.87% 44.44% -100.92% 60.65%
Earnings from Continuing Operations 19.15% -2.43% 73.14% 29.50% 22.37%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 19.15% -2.43% 73.14% 29.50% 22.37%
EBIT -2.37% -7.17% 6.93% 25.02% 10.59%
EBITDA -4.71% -9.87% 5.38% 23.07% 8.58%
EPS Basic 26.42% 7.01% 73.95% 30.53% 23.51%
Normalized Basic EPS 2.56% -2.37% 11.67% 25.12% 19.63%
EPS Diluted 26.42% 7.01% 73.95% 31.07% 23.51%
Normalized Diluted EPS 2.56% -2.37% 11.67% 25.12% 19.63%
Average Basic Shares Outstanding 9.90% 10.11% 3.11% 1.49% 1.47%
Average Diluted Shares Outstanding 9.90% 10.11% 3.11% 1.49% 1.47%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings